|
GPR107 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.91213999999329E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.523800E-02 |
| Normal-vs-Stage2 |
1.230150E-02 |
| Normal-vs-Stage3 |
1.89000000094808E-08 |
| Normal-vs-Stage4 |
6.10670000011915E-07 |
| Stage1-vs-Stage2 |
2.740000E-01 |
| Stage1-vs-Stage3 |
2.04579999999455E-05 |
| Stage1-vs-Stage4 |
2.430900E-04 |
| Stage2-vs-Stage3 |
5.046000E-02 |
| Stage2-vs-Stage4 |
7.661900E-02 |
| Stage3-vs-Stage4 |
9.882800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.25599999998028E-06 |
| Normal-vs-AfricanAmerican |
4.213800E-02 |
| Normal-vs-Asian |
3.953000E-01 |
| Caucasian-vs-AfricanAmerican |
4.405400E-01 |
| Caucasian-vs-Asian |
4.555800E-02 |
| AfricanAmerican-vs-Asian |
1.519040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.55099999998853E-06 |
| Normal-vs-Female |
4.897100E-03 |
| Male-vs-Female |
3.779900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.395750E-01 |
| Normal-vs-Age(41-60Yrs) |
1.722320E-03 |
| Normal-vs-Age(61-80Yrs) |
1.50470000004344E-06 |
| Normal-vs-Age(81-100Yrs) |
2.950000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.955600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.710200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.248400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.975900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.098800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.735400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.097800E-01 |
| Normal-vs-Grade 2 |
9.297300E-03 |
| Normal-vs-Grade 3 |
1.49370000002147E-06 |
| Normal-vs-Grade 4 |
8.91839999628274E-08 |
| Grade 1-vs-Grade 2 |
1.861700E-02 |
| Grade 1-vs-Grade 3 |
1.924090E-03 |
| Grade 1-vs-Grade 4 |
1.958000E-04 |
| Grade 2-vs-Grade 3 |
5.658400E-03 |
| Grade 2-vs-Grade 4 |
1.567680E-04 |
| Grade 3-vs-Grade 4 |
1.034370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.511600E-02 |
| Normal-vs-ccB subtype |
3.06240000003122E-06 |
| ccA subtype-vs-ccB subtype |
4.967300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.436690E-04 |
| Normal-vs-N1 |
7.489600E-01 |
| N0-vs-N1 |
4.429600E-01 |
|
|
